To lactating mothers, breast pumps come in very handy and essential as they journey through post-natal experiences, child nurturing and upbringing.
As old as time, Breast pumps are devices that enable breastfeeding women to extract breast milk for their young ones in events they are away from or unavailable to feed their babies directly. Breast pumps can also be used to take out breast milk for charity or to expel excess breast fluids.
The business of making breast pump devices has evolved and witnessed modifications in sizes, function and efficiency – from handheld and foot-operated, to electric and automated devices.
Annabella, a breast pump provider based in Kfar Saba, Israel, has successfully secured $8.5 million in Seed funding to support its mission of revolutionizing breastfeeding technology and accessibility. The funding round was spearheaded by notable investors, including Yasmin Lukatz, known for her role on Shark Tank and as the Founder of Israel Collaboration Network, Oren Dobronsky, Zohar Gilon from Tamar Technology Ventures, and Menachem Weinfeld from Starry Group. Notably, this Seed funding also saw a significant contribution from a crowdfunding campaign, amassing over $3 million.
The primary focus of utilizing these funds will be to expedite product development, extend market presence into the United States, and establish collaborations with insurance providers. Annabella aims to leverage these resources to make breast pumping more accessible to a wider audience.
Under the leadership of Masha Waldberg, Annabella made its market debut with an FDA-cleared, patented breast pump. What sets this innovative device apart is its ability to simulate a baby’s natural suckling motion. The pump includes an adjustable breast shield, prioritizing both efficiency and comfort in the breastfeeding process. Since its introduction in February 2023, Annabella has successfully sold over 4,000 breast pumps through partnerships with Shilav’s retail stores in Israel.
The significance of Annabella’s approach lies in its commitment to redefining the breastfeeding experience for mothers. By replicating a baby’s natural suckling, the FDA-cleared breast pump stands out as a solution that not only enhances efficiency but also prioritizes the comfort of mothers during the breastfeeding journey.
Furthermore, the strategic focus on collaborating with insurance providers reveals Annabella’s commitment to addressing accessibility challenges. By partnering with insurance entities, the company aims to make its breast pumping technology more financially attainable for a diverse range of users.
In conclusion, Annabella’s recent Seed funding success marks a significant milestone in its journey to redefine breastfeeding technology. With a proven track record in the Israeli market and a strong financial foundation, the company is well-positioned to bring about positive changes in the breastfeeding landscape. The innovative approach, coupled with strategic partnerships and funding support, positions Annabella as a key player in shaping the future of breastfeeding technology and accessibility.
